Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

GLYCO-N GLYCOprotein N-glycosylation from non-life to eukaryotes: a Doctoral Network to expand the knowledge on a ubiquitous posttranslational modification of proteins

Coordinator
Universita Degli Studi Di Napoli Federico Ii, Italy
Runs
1 February 2024 to 31 March 2028
Status
Running
EU funding
€2.7m
Total cost
—
Partners
17 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101119499

What the project is doing

In the project's own words, from its summary on CORDIS.

The GLYCO-N training network aims at training Doctoral Candidates (DCs) to acquire the skills to develop different innovative strategies to 1) understand the diversity and structural complexity of archaeal, microalgal and viral N-glycosylation and 2) harness this knowledge for new solutions in biomedicine and biotechnology. Protein N-glycosylation, or the attachment of oligo- and polysaccharides at specific asparagine residues, is conserved throughout life, and is now observed even in the viral world.

In contrast to eukaryotes, whose well-studied N-glycosylation machineries are relatively simple, archaea, microalgae and bacteria utilize a wide variety of monosaccharides to create a wealth of structurally diverse N-glycans, and the same holds true for some recently discovered viruses. Because protein glycosylation occurs far downstream of protein synthesis the complexity and diversity in N-glycan structures are poorly understood in detail.

This holds true specifically for N-glycosylation events that are the subject of the GLYCO-N program: those in archaea, microalgae and viruses. Understanding of the how and why of N-glycosylation in archaea, microalgae and viruses will open up many possibilities ranging from drug discovery (antivirals) to biotechnology (glycoprotein and glycoprocessing enzyme engineering for materials and life sciences). The GLYCO-N network brings together a diverse group of glycobiology researchers with world-leading expertise in microbiology, (bio)organic chemistry, computational and structural biology, bioinformatics and chemical biology.

The GLYCO-N DCs will have their own individual project with one GLYCO-N expert and will, through research internships, be exposed to complementary Glycoscience. All individual PhD projects, while rooted in fundamental science, have a practical application, either in biotechnology or in biomedicine, as will be explored through secondments with our associated partners.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di Napoli Federico IiNapoliItalyCoordinator
Technische Universitaet DresdenDresdenGermanyAssociatedpartner
Universitaet Duisburg-EssenEssenGermanyParticipant
Danmarks Tekniske UniversitetKongens LyngbyDenmarkParticipant
Adaptam Therapeutics SLSan SebastianSpainAssociatedpartner
Asociacion Centro De Investigacion Cooperativa En Biociencias Cic BioguneDerio VizcayaSpainParticipant
Atlas Molecular Pharma SLDerioSpainAssociatedpartner
Universidad Del Pais Vasco/ Euskal Herriko UnibertsitateaLeioaSpainAssociatedpartner
Universitat De BarcelonaBarcelonaSpainParticipant
Alga BiologicsIsneauvilleFranceAssociatedpartner
SamabrivaAmiensFranceAssociatedpartner
Universite De Rouen NormandieMont Saint Aignan CedexFranceParticipant
Innovation Acta SRLSienaItalyAssociatedpartner
Isuschem s.r.l.NapoliItalyAssociatedpartner
Universiteit LeidenLeidenNetherlandsParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomAssociatedpartner
The Francis Crick Institute LimitedLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI